Press "Enter" to skip to content

New patent expiration for ASPEN drug ENJUVIA

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for ASPEN drug ENJUVIA

Annual Drug Patent Expirations for ENJUVIA
Annual Drug Patent Expirations for ENJUVIA

Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this drug.

This drug has seventeen patent family members in nine countries.

The generic ingredient in ENJUVIA is estrogens, conjugated synthetic b. Additional details are available on the estrogens, conjugated synthetic b profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for ASPEN drug ENJUVIA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions